Role of melatonin in respiratory diseases (Review)
- Authors:
- Lijie Li
- Xiaochao Gang
- Jiajia Wang
- Xiaoyan Gong
-
Affiliations: Department of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China, Department of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China, Department of Pediatrics, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China, Department of Respiratory Medicine, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China - Published online on: February 9, 2022 https://doi.org/10.3892/etm.2022.11197
- Article Number: 271
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, et al: Prevalence, risk factors, and management of asthma in China: A national cross-sectional study. Lancet. 394:407–418. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yach D, Hawkes C, Gould CL and Hofman KJ: The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA. 291:2616–2622. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD and Tejada-Vera B: Deaths: Final data for 2006. Natl Vital Stat Rep. 57:1–134. 2009.PubMed/NCBI | |
|
Orens JB, Shearon TH, Freudenberger RS, Conte JV, Bhorade SM and Ardehali A: Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant. 6 (5 Pt 2):1188–1197. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM and Hertz MI: Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 26:782–795. 2007.PubMed/NCBI View Article : Google Scholar | |
|
O'Beirne S, Counihan IP and Keane MP: Interstitial lung disease and lung transplantation. Semin Respir Crit Care Med. 31:139–146. 2010.PubMed/NCBI View Article : Google Scholar | |
|
King TE Jr, Pardo A and Selman M: Idiopathic pulmonary fibrosis. Lancet. 378:1949–1961. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R and Reiter RJ: Melatonin synthesis and function: Evolutionary history in animals and plants. Front Endocrinol (Lausanne). 10(249)2019.PubMed/NCBI View Article : Google Scholar | |
|
Back K, Tan DX and Reiter RJ: Melatonin biosynthesis in plants: Multiple pathways catalyze tryptophan to melatonin in the cytoplasm or chloroplasts. J Pineal Res. 61:426–437. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX and Reiter RJ: Melatonin: An ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 59:403–419. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R: Melatonin, hormone of darkness and more: Occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci. 65:2001–2018. 2008.PubMed/NCBI View Article : Google Scholar | |
|
De Luca V, Marineau C and Brisson N: Molecular cloning and analysis of cDNA encoding a plant tryptophan decarboxylase: Comparison with animal dopa decarboxylases. Proc Natl Acad Sci USA. 86:2582–2586. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Park M, Kang K, Park S and Back K: Conversion of 5-hydroxytryptophan into serotonin by tryptophan decarboxylase in plants, Escherichia coli, and yeast. Biosci Biotechnol Biochem. 72:2456–2458. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z and Reiter RJ: Melatonin as a potent and inducible endogenous antioxidant: Synthesis and Metabolism. Molecules. 20:18886–18906. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Axelrod J and Weissbach H: Enzymatic O-methylation of N-acetylserotonin to melatonin. Science. 131(1312)1960.PubMed/NCBI View Article : Google Scholar | |
|
Kang K, Lee K, Park S, Byeon Y and Back K: Molecular cloning of rice serotonin N-acetyltransferase, the penultimate gene in plant melatonin biosynthesis. J Pineal Res. 55:7–13. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Byeon Y, Choi GH, Lee HY and Back K: Melatonin biosynthesis requires N-acetylserotonin methyltransferase activity of caffeic acid O-methyltransferase in rice. J Exp Bot. 66:6917–6925. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Byeon Y, Lee HJ, Lee HY and Back K: Cloning and functional characterization of the Arabidopsis N-acetylserotonin O-methyltransferase responsible for melatonin synthesis. J Pineal Res. 60:65–73. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Klein DC: Arylalkylamine N-acetyltransferase: ‘The Timezyme’. J Biol Chem. 282:4233–4237. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Favero G, Moretti E, Bonomini F, Reiter RJ, Rodella LF and Rezzani R: Promising antineoplastic actions of melatonin. Front Pharmacol. 9(1086)2018.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF and Xu K: Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis. Int J Mol Sci. 18(843)2017.PubMed/NCBI View Article : Google Scholar | |
|
Sanchez-Barcelo EJ, Rueda N, Mediavilla MD, Martinez-Cue C and Reiter RJ: Clinical uses of melatonin in neurological diseases and mental and behavioural disorders. Curr Med Chem. 24:3851–3878. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX and Reiter RJ: Melatonin, energy metabolism, and obesity: A review. J Pineal Res. 56:371–381. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Favero G, Franceschetti L, Bonomini F, Rodella LF and Rezzani R: Melatonin as an Anti-Inflammatory agent modulating inflammasome activation. Int J Endocrinol. 2017(1835195)2017.PubMed/NCBI View Article : Google Scholar | |
|
Ma N, Zhang J, Reiter RJ and Ma X: Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation. Med Res Rev. 40:606–632. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Moradkhani F, Moloudizargari M, Fallah M, Asghari N, Heidari Khoei H and Asghari MH: Immunoregulatory role of melatonin in cancer. J Cell Physiol. 235:745–757. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Alghamdi BS: The neuroprotective role of melatonin in neurological disorders. J Neurosci Res. 96:1136–1149. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ji G, Zhou W, Li X, Du J, Li X and Hao H: Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a/449a cluster. Mol Med Rep. 23(187)2021.PubMed/NCBI View Article : Google Scholar | |
|
Al-Ghoul WM, Herman MD and Dubocovich ML: Melatonin receptor subtype expression in human cerebellum. Neuroreport. 9:4063–4068. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Klosen P, Lapmanee S, Schuster C, Guardiola B, Hicks D, Pevet P and Felder-Schmittbuhl MP: MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations. J Pineal Res. 67(e12575)2019.PubMed/NCBI View Article : Google Scholar | |
|
Meléndez J, Maldonado V and Ortega A: Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res. 21:653–658. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Lacoste B, Angeloni D, Dominguez-Lopez S, Calderoni S, Mauro A, Fraschini F, Descarries L and Gobbi G: Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain. J Pineal Res. 58:397–417. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ng KY, Leong MK, Liang H and Paxinos G: Melatonin receptors: distribution in mammalian brain and their respective putative functions. Brain Struct Funct. 222:2921–2939. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gerbier R, Ndiaye-Lobry D, Martinez de Morentin PB, Cecon E, Heisler LK, Delagrange P, Gbahou F and Jockers R: Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5-HT2C receptor heteromers in mouse brain. FASEB J. 35(e21161)2021.PubMed/NCBI View Article : Google Scholar | |
|
Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E and Boutin JA: Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem. 275:31311–31317. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Boutin JA and Ferry G: Is there sufficient evidence that the melatonin binding site MT3 Is quinone reductase 2? J Pharmacol Exp Ther. 368:59–65. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hasan ZT, Atrakji DMQYMAA and Mehuaiden DAK: The effect of melatonin on thrombosis, sepsis and mortality rate in COVID-19 Patients. Int J Infect Dis. 114:79–84. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Ziaei A, Davoodian P, Dadvand H, Safa O, Hassanipour S, Omidi M, Masjedi M, Mahmoudikia F, Rafiee B and Fathalipour M: Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 21(882)2020.PubMed/NCBI View Article : Google Scholar | |
|
Medzhitov R: Origin and physiological roles of inflammation. Nature. 454:428–435. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Kuprash DV and Nedospasov SA: Molecular and cellular mechanisms of inflammation. Biochemistry (Mosc). 81:1237–1239. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zarrin AA, Bao K, Lupardus P and Vucic D: Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov. 20:39–63. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang W and Gao J: Effects of melatonin on protecting against lung injury (Review). Exp Ther Med. 21(228)2021.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R: Melatonin and inflammation-Story of a double-edged blade. J Pineal Res. 65(e12525)2018.PubMed/NCBI View Article : Google Scholar | |
|
Mańka S and Majewska E: Immunoregulatory action of melatonin. The mechanism of action and the effect on inflammatory cells. Postepy Hig Med Dosw (Online). 70:1059–1067. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R, Cardinali DP, Brown GM and Pandi-Perumal SR: Melatonin and brain inflammaging. Prog Neurobiol. 127:–128. 46–63. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, Nayeri S, Schräder M and Carlberg C: The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem. 270:7037–7040. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Garcia-Mauriño S, Gonzalez-Haba MG, Calvo JR, Goberna R and Guerrero JM: Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells. J Neuroimmunol. 92:76–84. 1998.PubMed/NCBI View Article : Google Scholar | |
|
García-Mauriño S, Pozo D, Calvo JR and Guerrero JM: Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res. 29:129–137. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Carrillo-Vico A, García-Mauriño S, Calvo JR and Guerrero JM: Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J. 17:755–757. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Lardone PJ, Carrillo-Vico A, Naranjo MC, De Felipe B, Vallejo A, Karasek M and Guerrero JM: Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production. J Cell Physiol. 206:273–279. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Kuklina EM, Glebezdina NS and Nekrasova IV: Role of melatonin in the regulation of differentiation of T cells producing interleukin-17 (Th17). Bull Exp Biol Med. 160:656–658. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kühlwein E and Irwin M: Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J Neuroimmunol. 117:51–57. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R, Reiter RJ, Poeggeler B and Tan DX: The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev. 17:347–357. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Poeggeler B, Reiter RJ, Tan DX, Chen LD and Manchester LC: Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res. 14:151–168. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ: Functional pleiotropy of the neurohormone melatonin: Antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol. 16:383–415. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ, Tan DX, Manchester LC, Lopez-Burillo S, Sainz RM and Mayo JC: Melatonin: Detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol. 527:539–548. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Tamura H, Jozaki M, Tanabe M, Shirafuta Y, Mihara Y, Shinagawa M, Tamura I, Maekawa R, Sato S, Taketani T, et al: Importance of melatonin in assisted reproductive technology and ovarian aging. Int J Mol Sci. 21(1135)2020.PubMed/NCBI View Article : Google Scholar | |
|
Moniruzzaman M, Ghosal I, Das D and Chakraborty SB: Melatonin ameliorates H2O2-induced oxidative stress through modulation of Erk/Akt/NFkB pathway. Biol Res. 51(17)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lissoni P, Brivio O, Brivio F, Barni S, Tancini G, Crippa D and Meregalli S: Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. J Pineal Res. 21:239–242. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS and Kopff HS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 59:4693–4701. 1999.PubMed/NCBI | |
|
Blask DE, Dauchy RT, Brainard GC and Hanifin JP: Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: Consequences of its disruption by light at night in rats and women. Integr Cancer Ther. 8:347–353. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E and Sauer LA: Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res. 51:259–269. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Susa N, Ueno S, Furukawa Y, Ueda J and Sugiyama M: Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol. 144:377–384. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Tan DX, Pöeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC and Barlow-Walden LR: The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:65–71. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Kilic E, Kilic U, Reiter RJ, Bassetti CL and Hermann DM: Prophylactic use of melatonin protects against focal cerebral ischemia in mice: Role of endothelin converting enzyme-1. J Pineal Res. 37:247–251. 2004.PubMed/NCBI View Article : Google Scholar | |
|
León J, Casado J, Jiménez Ruiz SM, Zurita MS, González-Puga C, Rejón JD, Gila A, Muñoz de Rueda P, Pavón EJ, Reiter RJ, et al: Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-κβ. J Pineal Res. 56:415–426. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Obeng E: Apoptosis (programmed cell death) and its signals-A review. Braz J Biol. 81:1133–1143. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Jang MH, Jung SB, Lee MH, Kim CJ, Oh YT, Kang I, Kim J and Kim EH: Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett. 380:26–31. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Yoo YM, Yim SV, Kim SS, Jang HY, Lea HZ, Hwang GC, Kim JW, Kim SA, Lee HJ, Kim CJ, et al: Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells. J Pineal Res. 33:146–150. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Joo SS and Yoo YM: Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: Therapeutic implications for prostate cancer. J Pineal Res. 47:8–14. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Mayo JC, Sainz RM, Uría H, Antolín I, Estéban MM and Rodríguez : Inhibition of cell proliferation: A mechanism likely to mediate the prevention of neuronal cell death by melatonin. J Pineal Res. 25:12–18. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Han Z, Battaglia F and Terlecky SR: Discharged COVID-19 patients testing positive again for SARS-CoV-2 RNA: A minireview of published studies from China. J Med Virol. 93:262–274. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Salehi S, Abedi A, Balakrishnan S and Gholamrezanezhad A: Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. AJR Am J Roentgenol. 215:87–93. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Simko F, Hrenak J, Dominguez-Rodriguez A and Reiter RJ: Melatonin as a putative protection against myocardial injury in COVID-19 infection. Expert Rev Clin Pharmacol. 13:921–924. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tan DX and Hardeland R: Targeting host defense system and rescuing compromised mitochondria to increase tolerance against pathogens by melatonin may impact outcome of deadly virus infection pertinent to COVID-19. Molecules. 25(4410)2020.PubMed/NCBI View Article : Google Scholar | |
|
Cross KM, Landis DM, Sehgal L and Payne JD: Melatonin in early treatment for COVID-19: A narrative review of current evidence and possible efficacy. Endocr Pract. 27:850–855. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, Gack MU, Farha S, Zein J, Comhair S, et al: A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. 18(e3000970)2020.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ, Abreu-Gonzalez P, Marik PE and Dominguez-Rodriguez A: Therapeutic algorithm for use of melatonin in patients with COVID-19. Front Med (Lausanne). 7(226)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C and Reiter RJ: COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 250(117583)2020.PubMed/NCBI View Article : Google Scholar | |
|
Cardinali DP, Brown GM, Reiter RJ and Pandi-Perumal SR: Elderly as a high-risk group during COVID-19 pandemic: Effect of circadian misalignment, sleep dysregulation and melatonin administration. Sleep Vigil. 1–7. 2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print). | |
|
Huang SH, Cao XJ, Liu W, Shi XY and Wei W: Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J Pineal Res. 48:109–116. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Shneider A, Kudriavtsev A and Vakhrusheva A: Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 39:153–162. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Campos LA, Cipolla-Neto J, Amaral FG, Michelini LC, Bader M and Baltatu OC: The Angiotensin-melatonin axis. Int J Hypertens. 2013(521783)2013.PubMed/NCBI View Article : Google Scholar | |
|
Zhang HM and Zhang Y: Melatonin: A well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res. 57:131–146. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang R, Hozumi Y, Yin C and Wei GW: Mutations on COVID-19 diagnostic targets. Genomics. 112:5204–5213. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jia Z and Gong W: Will mutations in the spike protein of SARS-CoV-2 lead to the failure of COVID-19 Vaccines? J Korean Med Sci. 36(e124)2021.PubMed/NCBI View Article : Google Scholar | |
|
Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, Agrawal M and Alexander A: Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 883(173375)2020.PubMed/NCBI View Article : Google Scholar | |
|
Raherison C and Girodet PO: Epidemiology of COPD. Eur Respir Rev. 18:213–221. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Negewo NA, Gibson PG and McDonald VM: COPD and its comorbidities: Impact, measurement and mechanisms. Respirology. 20:1160–1171. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al: International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 370:741–750. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Menn P, Heinrich J, Huber RM, Jörres RA, John J, Karrasch S, Peters A, Schulz H and Holle R: KORA Study Group. Direct medical costs of COPD-an excess cost approach based on two population-based studies. Respir Med. 106:540–548. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yong W, Ma H, Na M, Gao T, Zhang Y, Hao L, Yu H, Yang H and Deng X: Roles of melatonin in the field of reproductive medicine. Biomed Pharmacother. 144(112001)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mao K, Luo P, Geng W, Xu J, Liao Y, Zhong H, Ma P, Tan Q, Xia H, Duan L, et al: An integrative transcriptomic and metabolomic study revealed that melatonin plays a protective role in chronic lung inflammation by reducing necroptosis. Front Immunol. 12(668002)2021.PubMed/NCBI View Article : Google Scholar | |
|
Shin NR, Ko JW, Kim JC, Park G, Kim SH, Kim MS, Kim JS and Shin IS: Role of melatonin as an SIRT1 enhancer in chronic obstructive pulmonary disease induced by cigarette smoke. J Cell Mol Med. 24:1151–1156. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shin NR, Park JW, Lee IC, Ko JW, Park SH, Kim JS, Kim JC, Ahn KS and Shin IS: Melatonin suppresses fibrotic responses induced by cigarette smoke via downregulation of TGF-β1. Oncotarget. 8:95692–95703. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mahalanobish S, Dutta S, Saha S and Sil PC: Melatonin induced suppression of ER stress and mitochondrial dysfunction inhibited NLRP3 inflammasome activation in COPD mice. Food Chem Toxicol. 144(111588)2020.PubMed/NCBI View Article : Google Scholar | |
|
Shin IS, Shin NR, Park JW, Jeon CM, Hong JM, Kwon OK, Kim JS, Lee IC, Kim JC, Oh SR and Ahn KS: Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. J Pineal Res. 58:50–60. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hung MW, Yeung HM, Lau CF, Poon AMS, Tipoe GL and Fung ML: Melatonin attenuates pulmonary hypertension in chronically hypoxic rats. Int J Mol Sci. 18(1125)2017.PubMed/NCBI View Article : Google Scholar | |
|
Kim GD, Lee SE, Kim TH, Jin YH, Park YS and Park CS: Melatonin suppresses acrolein-induced IL-8 production in human pulmonary fibroblasts. J Pineal Res. 52:356–364. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Pieper MP: The non-neuronal cholinergic system as novel drug target in the airways. Life Sci. 91:1113–1118. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the year 2020: An overview. Int J Cancer. 2021.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print). | |
|
Carter-Harris L, Ceppa DP, Hanna N and Rawl SM: Lung cancer screening: What do long-term smokers know and believe? Health Expect. 20:59–68. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Pinsky P and Gierada DS: Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans. Lung Cancer. 139:179–184. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and Buchanan P: Lung cancer: Biology and treatment options. Biochim Biophys Acta. 1856:189–210. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Vinod SK and Hau E: Radiotherapy treatment for lung cancer: Current status and future directions. Respirology. 25 (Suppl 2):S61–S71. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lissoni P, Chilelli M, Villa S, Cerizza L and Tancini G: Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: A randomized trial. J Pineal Res. 35:12–15. 2003.PubMed/NCBI View Article : Google Scholar | |
|
García-Navarro A, González-Puga C, Escames G, López LC, López A, López-Cantarero M, Camacho E, Espinosa A, Gallo MA and Acuña-Castroviejo D: Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res. 43:195–205. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Tam CW, Mo CW, Yao KM and Shiu SY: Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: Implications for prostate cancer chemoprevention. J Pineal Res. 42:191–202. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Benítez-King G, Soto-Vega E and Ramírez-Rodriguez G: Melatonin modulates microfilament phenotypes in epithelial cells: Implications for adhesion and inhibition of cancer cell migration. Histol Histopathol. 24:789–799. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Mediavilla MD, Cos S and Sánchez-Barceló EJ: Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65:415–420. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Zhou Q, Gui S, Zhou Q and Wang Y: Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway. PloS One. 9(e101132)2014.PubMed/NCBI View Article : Google Scholar | |
|
Haus E, Dumitriu L, Nicolau GY, Bologa S and Sackett-Lundeen L: Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer. Chronobiol Int. 18:709–727. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Fan C, Pan Y, Yang Y, Di S, Jiang S, Ma Z, Li T, Zhang Z, Li W, Li X, et al: HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways. J Pineal Res. 59:321–333. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Xiao X, Zhang Y, Shi D, Chen W, Fu L, Liu L, Xie F, Kang T, Huang W and Deng W: Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res. 53:77–90. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lu JJ, Fu L, Tang Z, Zhang C, Qin L, Wang J, Yu Z, Shi D, Xiao X, Xie F, et al: Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget. 7:2985–3001. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, García-Mauriño S, Reiter RJ and Guerrero JM: Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 18:537–539. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ, Tan DX, Sainz RM, Mayo JC and Lopez-Burillo S: Melatonin: Reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 54:1299–1321. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Rockey DC, Bell PD and Hill JA: Fibrosis-a common pathway to organ injury and failure. N Engl J Med. 372:1138–1149. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A and Delbono O: Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am J Physiol Cell Physiol. 305:C1098–C1113. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Drobnik J, Karbownik-Lewińska M, Szczepanowska A, Słotwińska D, Olczak S, Jakubowski L and Dabrowski R: Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar. J Pineal Res. 45:285–290. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L and San Antonio JD: Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem. 277:4223–4231. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Pugazhenthi K, Kapoor M, Clarkson AN, Hall I and Appleton I: Melatonin accelerates the process of wound repair in full-thickness incisional wounds. J Pineal Res. 44:387–396. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ding Z, Wu X, Wang Y, Ji S, Zhang W, Kang J, Li J and Fei G: Melatonin prevents LPS-induced epithelial-mesenchymal transition in human alveolar epithelial cells via the GSK-3β/Nrf2 pathway. Biomed Pharmacother. 132(110827)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yildirim Z, Kotuk M, Erdogan H, Iraz M, Yagmurca M, Kuku I and Fadillioglu E: Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res. 40:27–33. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Genovese T, Di Paola R, Mazzon E, Muià C, Caputi AP and Cuzzocrea S: Melatonin limits lung injury in bleomycin treated mice. J Pineal Res. 39:105–112. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Karimfar MH, Rostami S, Haghani K, Bakhtiyari S and Noori-Zadeh A: Melatonin alleviates bleomycin-induced pulmonary fibrosis in mice. J Biol Regul Homeost Agents. 29:327–334. 2015.PubMed/NCBI | |
|
Hosseinzadeh A, Javad-Moosavi SA, Reiter RJ, Hemati K, Ghaznavi H and Mehrzadi S: Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin. Life Sci. 201:17–29. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Alvarez-García V, González A, Alonso-González C, Martínez-Campa C and Cos S: Antiangiogenic effects of melatonin in endothelial cell cultures. Microvasc Res. 87:25–33. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Alvarez-García V, González A, Alonso-González C, Martínez-Campa C and Cos S: Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. J Pineal Res. 54:373–380. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Song J, Kang SM, Lee WT, Park KA, Lee KM and Lee JE: The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury. Oxid Med Cell Longev. 2014(639531)2014.PubMed/NCBI View Article : Google Scholar | |
|
Crespo I, San-Miguel B, Fernández A, Ortiz de Urbina J, González-Gallego J and Tuñón MJ: Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice. Transl Res. 165:346–357. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Czechowska G, Celinski K, Korolczuk A, Wojcicka G, Dudka J, Bojarska A and Reiter RJ: Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats. J Physiol Pharmacol. 66:567–579. 2015.PubMed/NCBI | |
|
Yip HK, Chang YC, Wallace CG, Chang LT, Tsai TH, Chen YL, Chang HW, Leu S, Zhen YY, Tsai CY, et al: Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res. 54:207–221. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Finsnes F, Skjønsberg OH, Lyberg T and Christensen G: Endothelin-1 production is associated with eosinophilic rather than neutrophilic airway inflammation. Eur Respir J. 15:743–750. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Ji ZZ and Xu YC: Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model. Mol Med Rep. 14:920–926. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Montero P, Milara J, Roger I and Cortijo J: Role of JAK/STAT in interstitial lung diseases; Molecular and cellular mechanisms. Int J Mol Sci. 22(6211)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Chen L, Chen B, Meliton A, Liu SQ, Shi Y, Liu T, Deb DK, Solway J and Li YC: Chronic activation of the renin-angiotensin system induces lung fibrosis. Sci Rep. 5(15561)2015.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Molina-Molina M, Abdul-Hafez A, Ramirez J, Serrano-Mollar A, Xaubet A and Uhal BD: Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 291:L887–L895. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Uhal BD, Dang MT, Li X and Abdul-Hafez A: Angiotensinogen gene transcription in pulmonary fibrosis. Int J Pept. 2012(875910)2012.PubMed/NCBI View Article : Google Scholar | |
|
Andersen LP, Gögenur I, Rosenberg J and Reiter RJ: The safety of melatonin in humans. Clin Drug Investig. 36:169–175. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Habtemariam S, Daglia M, Sureda A, Selamoglu Z, Gulhan MF and Nabavi SM: Melatonin and respiratory diseases: A review. Curr Top Med Chem. 17:467–488. 2017.PubMed/NCBI View Article : Google Scholar |
